Sitaram Gupta from Lupin Foundation bags ‘India CSR Lifetime Achievement Award’
Gupta received the award for his extraordinary contribution towards social development
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Lupin launches Testosterone Gel
Lupin’s Testosterone Gel, 1.62 per cent (20.25 mg/1.25 g pump actuation), is the generic equivalent of AbbVie Inc’s AndroGel, 1.62…
Cipla launches Niveoli – India’s first extra-fine ICS-LABA combination HFA inhaler
Niveoli is a proprietary Cipla inhaler that addresses an unmet need associated with obstructive airway diseases (OAD) such as…
Indian Pharma sector growth to moderate at 8-10% CAGR over FY’2018-21: ICRA
High base for domestic business impacted Q3FY2019 growth, and moderation in pricing pressure, new launches and currency…
Wockhardt receives US FDA approval for cancer drug
This is the third US FDA approval for an oncology product for Wockhardt during the past three months
US FDA approves ViiV Healthcare’s Dovato
Dovato strengthens ViiV Healthcare’s industry-leading portfolio of innovative treatment approaches for people living with HIV
Lupin launches Fluoxetine tabs
The drug is indicated in the treatment of major depressive disorder, obsessive compulsive disorder, bulimia nervosa
Global eye care giant Alcon lists at Swiss Exchange
The listing is expected to be one of Europe’s largest in the coming year and will be split across SIX and the NYSE
Keynote address: Transforming pharma with disruptive technologies
Shaunak Dave, CEO, Optel Asia gave a rousing key note address on the first day of Pharma CXO Summit 2019 which centred on the…
Intas Pharma launches Trastuzumab biosimilar
Eleftha will bring down the treatment cost by 65 per cent